← Back to headlines
Oppenheimer Upgrades Bicycle Therapeutics to Outperform
Oppenheimer has initiated coverage of Bicycle Therapeutics with an 'outperform' rating, citing the company's platform for treating cancer as a key factor.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
